Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study

Fig. 2

A Relationship between LDL-C and LDL-MI before pemafibrate. The regression line and its 95% confidence interval are shown (R2 = 0.4283, P < 0.0001, least squares method). B Relationship between percent increase in LDL-C and LDL-MI before pemafibrate. The regression line and its 95% confidence interval are shown (R2 = 0.6017, P < 0.0001)

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X